GYREGyre Therapeutics, Inc.Nov 12, 2021Q3 2021
Read transcript →Gyre Therapeutics, Inc. (GYRE) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$5.66
-5.51%
Mkt Cap $549.26M
GYREGyre Therapeutics, Inc.Nov 12, 2021GYREGyre Therapeutics, Inc.Nov 5, 2014Q3 2014
Read transcript →GYREGyre Therapeutics, Inc.Aug 6, 2014Q2 2014
Read transcript →GYREGyre Therapeutics, Inc.May 7, 2014Q1 2014
Read transcript →GYREGyre Therapeutics, Inc.Feb 13, 2014Q4 2013
Read transcript →GYREGyre Therapeutics, Inc.Nov 5, 2013Q3 2013
Read transcript →GYREGyre Therapeutics, Inc.Aug 6, 2013Q2 2013
Read transcript →GYREGyre Therapeutics, Inc.May 7, 2013Q1 2013
Read transcript →GYREGyre Therapeutics, Inc.Feb 13, 2013Q4 2012
Read transcript →GYREGyre Therapeutics, Inc.Nov 6, 2012Q3 2012
Read transcript →GYREGyre Therapeutics, Inc.Aug 8, 2012Q2 2012
Read transcript →GYREGyre Therapeutics, Inc.Feb 12, 2010Q4 2009
Read transcript →GYREGyre Therapeutics, Inc.Nov 5, 2009Q3 2009
Read transcript →GYREGyre Therapeutics, Inc.Aug 5, 2009Q2 2009
Read transcript →GYREGyre Therapeutics, Inc.Feb 12, 2009Q4 2008
Read transcript →GYREGyre Therapeutics, Inc.Nov 20, 2008Q3 2008
Read transcript →GYREGyre Therapeutics, Inc.Aug 5, 2008Q2 2008
Read transcript →